West Hill Capital

ATLANT 3D Nanosystems is a global pioneer combining unique advanced technologies to enable atomic layer 3D printing. The company was founded in 2018 by Dr. Maksym Plakhotnyuk, Ivan Kundrata, and Prof. Dr. Julien Bachmann with a vision of delivering the first-ever atomic layer 3D printing technology to reshape the future atom by atom. Our state-of-the-art atomic layer 3D printing technology is a true European creation, supported by three major European universities: Technical University of Denmark, Institute of Electrical Engineering Slovak Academy of Sciences, and Friedrich Alexander University Erlangen-Nuremberg.

AddiFab ApS manufactures 3D printing machinery. The company was incorporated in 2014 and is based in Jyllinge, Denmark.

Particle3D is a Danish biomedical engineering company founded in 2017, specializing in the development of 3D printed implants tailored for patients. With over three years of research backing its innovations, the company focuses on creating patient-fitted bone replacement implants made from natural materials. Particle3D aims to transform the treatment landscape for craniofacial patients by offering advanced solutions that enhance surgical procedures and patient outcomes. The technology is designed to improve aesthetic and functional results, promote faster recovery, reduce complications, and streamline surgeries, ultimately increasing hospital productivity. By setting new standards in craniofacial reconstruction, Particle3D is positioned to play a significant role in a commercially promising market segment.

Particle3D is a Danish biomedical engineering company founded in 2017, specializing in the development of 3D printed implants tailored for patients. With over three years of research backing its innovations, the company focuses on creating patient-fitted bone replacement implants made from natural materials. Particle3D aims to transform the treatment landscape for craniofacial patients by offering advanced solutions that enhance surgical procedures and patient outcomes. The technology is designed to improve aesthetic and functional results, promote faster recovery, reduce complications, and streamline surgeries, ultimately increasing hospital productivity. By setting new standards in craniofacial reconstruction, Particle3D is positioned to play a significant role in a commercially promising market segment.